MIRA Reports Preclinical Data
MIRA Pharmaceuticals reports new preclinical data demonstrating Mira-55's differentiated mechanism of action and anxiolytic activity relative to THC
MIRA - MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC